14 March 2024 - In TRANSCEND CLL 004, the first pivotal multicenter trial to evaluate a CAR T cell therapy in ...
18 March 2024 - FDA assigns Prescription Drug User Fee Act target action date of 13 August 2024 ...
18 March 2024 - The EMA has published a draft agenda for this week's CHMP meeting. ...
18 March 2024 - Today, the US FDA approved Lenmeldy (atidarsagene autotemcel), the first FDA approved gene therapy indicated for the ...
15 March 2024 - ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms ...
18 March 2024 - A consumer-led Co-design Working Group has developed proposed recommendations for enhancing consumer engagement processes to enable ...
17 March 2024 - Zymfentra is commercially available across the US on 15 March 2024. ...
14 March 2024 - Results from the global, Phase 3 RATIONALE 302 trial showed Tevimbra prolonged the survival of patients who ...
15 March 2024 - Pharmac has decided to keep Rule 8.1b, which allows medicines for treating children with cancer to ...
15 March 2024 - ImmVira has recently announced that the US FDA has granted fast track designation for oncolytic virus product ...
15 March 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2023 PBAC ...
14 March 2024 - Health Canada's approval is supported by Phase III clinical trial data which found Bimzelx provided significant improvement ...
14 March 2024 - Keros Therapeutics today announced that the US FDA has granted fast track designation for KER-050 (elritercept) for ...
14 March 2024 - Medicare Part D plans statutorily cannot cover anti-obesity medications, but state Medicaid programs have more flexibility. ...
14 March 2024 - Today, the US FDA approved Rezdiffra (resmetirom) for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis with ...